Metarbitale [Dcit] en es it fr

Metarbitale [Dcit] Brand names, Metarbitale [Dcit] Analogs

Metarbitale [Dcit] Brand Names Mixture

  • No information avaliable

Metarbitale [Dcit] Chemical_Formula


Metarbitale [Dcit] RX_link

No information avaliable

Metarbitale [Dcit] fda sheet

Metarbitale [Dcit] msds (material safety sheet)

Metarbitale [Dcit] Synthesis Reference

No information avaliable

Metarbitale [Dcit] Molecular Weight

198.219 g/mol

Metarbitale [Dcit] Melting Point

150.5 oC

Metarbitale [Dcit] H2O Solubility

1980 mg/L

Metarbitale [Dcit] State


Metarbitale [Dcit] LogP


Metarbitale [Dcit] Dosage Forms


Metarbitale [Dcit] Indication

For the treatment of epilepsy

Metarbitale [Dcit] Pharmacology

Metharbital, a barbiturate, is used for the treatment of short term insomnia. It belongs to a group of medicines called central nervous system (CNS) depressants that induce drowsiness and relieve tension or nervousness. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.

Metarbitale [Dcit] Absorption

No information avaliable

Metarbitale [Dcit] side effects and Toxicity

Signs of overdose include confusion (severe), decrease in or loss of reflexes, drowsiness (severe), fever, irritability (continuing), low body temperature, poor judgment, shortness of breath or slow or troubled breathing, slow heartbeat, slurred speech, staggering, trouble in sleeping, unusual movements of the eyes, weakness (severe).

Metarbitale [Dcit] Patient Information

No information avaliable

Metarbitale [Dcit] Organisms Affected

Humans and other mammals